Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2025, Vol 14, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Review
1. A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
Anoush Azarfar, Mahin Ghorban Sabbagh, Yalda Ravanshad*, Mohammad Esmaeeli, Hassan MehradMajd, Azade Oveisi Sani, Sahar Ravanshad
J Renal Inj Prev
. 2019;8(2): 116-121.
doi:
10.15171/jrip.2019.22
Scopus ID:
85063791253
Article
PDF
XML
Cited By:
0
0
×
A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
Case Report
2. Hemolytic uremic syndrome following COVID-19; a case report
Elham Emami
, Samaneh Safari*, Pedram Javanmard
J Renal Inj Prev
. 2022;11(2): e31972.
doi:
10.34172/jrip.2022.31972
Scopus ID:
85130413351
Article
PDF
XML
Cited By:
0
0
×
Hemolytic uremic syndrome following COVID-19; a case report
